3 terminated, 1 recruiting. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 3, Recruiting 1 |
| Phase 2 | 2 | Terminated 2 |
Follow Ovary Neoplasm: new trials by email Literature Review of Ovary Neoplasm trials Research Report on Ovary Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells iC9-CAR.B7-H3 T cells, Cyclophosphamide, Fludarabine - Ovary Neoplasm, Ovarian Cancer | Phase 1 | Recruiting | UNC Lineberger Comprehensive Cancer Center | 27 | 2024-07-29 | 2026-05-19 |
| Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors Neoantigen specific TCR-T cell drug product, Aldesleukin (IL-2) - Gynecologic Cancer, Colorectal Cancer | Phase 1 / Phase 2 | Terminated | Alaunos Therapeutics | 8 | 2022-04-04 | 2025-11-10 |
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors NUV-868, Olaparib, Enzalutamide - Advanced Solid Tumor, Ovarian Cancer | Phase 1 | Terminated | Nuvation Bio Inc. | 82 | 2022-03-29 | 2025-11-06 |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRĪ±) ELU001 - Ovarian Cancer, Ovarian Neoplasms | Phase 1 / Phase 2 | Terminated | Elucida Oncology | 79 | 2021-09-13 | 2024-08-07 |
Ovarian Neoplasms (4) · Carcinoma, Ovarian Epithelial (2) · Endometrial Neoplasms (2) · Pancreatic Neoplasms (2) · Recurrence (2) · Adenocarcinoma of Lung (1) · Breast Neoplasms (1) · Carcinoma (1) · Carcinoma, Endometrioid (1) · Carcinoma, Non-Small-Cell Lung (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Fallopian Tube Neoplasms (1) · Krukenberg Tumor (1) · Ovarian Diseases (1)
Adnexal Diseases (4) · Endocrine Gland Neoplasms (4) · Endocrine System Diseases (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Genital Neoplasms, Female (4) · Gonadal Disorders (4) · Neoplasms (4) · Neoplasms by Site (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3)
Cyclophosphamide (1) · Interleukin-2 (1) · aldesleukin (1) · enzalutamide (1) · fludarabine (1) · fludarabine phosphate (1) · olaparib (1)
Alaunos Therapeutics (1) · Elucida Oncology (1) · Nuvation Bio Inc. (1) · UNC Lineberger Comprehensive Cancer Center (1)
United States (4) · Australia (1)
Linda Van Le, MD (1) · Scott Kopetz, MD, PhD (1)